Skip to main content
Fig. 4 | Malaria Journal

Fig. 4

From: Population pharmacokinetics and pharmacodynamics of the artesunate–mefloquine fixed dose combination for the treatment of uncomplicated falciparum malaria in African children

Fig. 4

Median and 90% prediction intervals of MQ concentration–time profiles for children and adult patients receiving 110 mg and 400 mg of MQ once per day over three consecutive days obtained with this study (children, magenta solid line and shaded surface), the Julien et al. (adult, light grey line and shaded surface), and Reuter et al. (adult, dark grey line and shaded surface) models, respectively [26, 27]

Back to article page